Cancer News and Research

Latest Cancer News and Research

ACR Image Metrix praises iCAD on FDA clearance of VeraLook Colon CAD software

ACR Image Metrix™, an imaging contract research organization (CRO) with expertise in imaging research design, techniques and data extraction, congratulates their partner, iCAD, Inc., on obtaining U.S. Food and Drug Administration clearance on its VeraLook™, Colon CAD (Computer-Aided Detection) software.

25 Aug 2010

NICE draft guidance rejects cancer drug bevacizumab

The National Institute for Health and Clinical Excellence (NICE) has released draft guidance for cancer drug bevacizumab (Avastin).

25 Aug 2010

BioScale installs ViBE analytical tool at Massachusetts-based pharmaceutical company

BioScale Inc., an innovative life science company that develops, manufactures and promotes novel analytical tools enabling advancements in protein research, today announced the first shipment and installation of the ViBE™ Protein Analysis Workstation at a major Massachusetts-based pharmaceutical company.

25 Aug 2010

Access Pharmaceuticals to highlight Cobalamin nanotechnology at ACS National Meeting

ACCESS PHARMACEUTICALS, INC.,a biopharmaceutical company specializing in products for cancer and supportive care, announced that its Director of Chemistry and Quality, Dr. Ric Zarzycki will give an invited presentation today on the Company's Cobalamin nanoparticle technology at a thought-leadership symposium being held at the American Chemical Society's ("ACS") 240th National Meeting & Exposition, at Boston Convention and Exhibition Center in Boston, Massachusetts, August 22-26, 2010.

25 Aug 2010

Fewer young women going for regular pap smears

According to new research findings, the number of young women going for a regular Pap smear test is dwindling. This test is a simple procedure that looks at the cervical cells and can detect cervical cancer early on. In 2001-02, 67% Australian women aged 20-69 went for a Pap smear, a number that went down to 60% in 2008-09. These are the lowest rates in the decade.

24 Aug 2010

Scientists discover influence of vitamin D in genes linked with autoimmune diseases

UK scientists at the University of Oxford have discovered that vitamin D can affect the activity of more than 200 genes of cells grown in the lab. Some of these genes are known from previous studies to be involved in diseases like diabetes and cancer.

24 Aug 2010

UNT Health Science Center analyzes DNA from unidentified human remains

Center for Human Identification at the University of North Texas Health Science Center (UNTHSC) analyzes DNA from unidentified human remains for law enforcement organizations and medical examiners across the country in an attempt to put a name to a body or victim. The result, in many cases, is resolution for family members who have spent years wondering about the fate of their loved one.

24 Aug 2010

3SBio and Isotechnika enter strategic agreement for voclosporin in China

3SBio Inc., a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products and Isotechnika Pharma Inc., a biopharmaceutical company focused on the discovery and development of immune modulating therapeutics, today announced the signing of a development and commercialization agreement for voclosporin.

24 Aug 2010

First patient treated in Synta Pharmaceuticals' clinical trial of STA-9090

Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that the first patient has been treated in its clinical trial of STA-9090 in combination with docetaxel for the treatment of advanced solid tumor malignancies.

24 Aug 2010

Aileron Therapeutics, Roche partner to develop, commercialise Stapled Peptide Therapeutics

Aileron Therapeutics and Roche announced today that they have entered into a collaboration to discover, develop and commercialise a new class of drugs called Stapled Peptide Therapeutics. As part of this agreement, Roche will work with Aileron to develop drug candidates against up to five undisclosed targets selected from Roche's key therapeutic areas, which include oncology, virology, inflammation, metabolism and CNS.

24 Aug 2010

First Edition: August 24, 2010

In today's headlines, a federal court judge blocks the Obama administration's stem cell policy. Meanwhile, state action related to health reform and health policy continues.

24 Aug 2010

FRC applauds preliminary injunction to stop taxpayers for embryonic stem cell research

Family Research Council President Tony Perkins applauded today's preliminary injunction that for now stops taxpayer funded embryonic stem cell research. Judge Royce Lamberth noted that the imposition of an injunction required that those challenging the government's funding demonstrate a substantial likelihood of success on the merits for their arguments.

24 Aug 2010

Raptor Pharmaceutical updates on cysteamine bitartrate Phase 3 clinical trial in cystinosis patients

Raptor Pharmaceutical Corp.,provides updates on timelines related to its clinical programs including the pivotal Phase 3 clinical trial of its proprietary delayed-release oral formulation of cysteamine bitartrate ("DR Cysteamine") in patients with nephropathic cystinosis ("cystinosis").

24 Aug 2010

EDAP's gross profit reduces 5.1% in 2010 second quarter

EDAP TMS SA, the global leader in therapeutic ultrasound, announced today financial results for the second quarter ended June 30, 2010. The Company outlines strategic initiatives to counter the continuing weak global economic climate.

24 Aug 2010

Walter and Eliza Hall Institute researcher receives L'Oreal Fellowship for breast cancer research

A desire to understand how breast cancer starts has seen Walter and Eliza Hall Institute researcher Dr Marie-Liesse Asselin-Labat today win one of three 2010 L'Oreal Australia For Women in Science Fellowships.

24 Aug 2010

Discovery of Hsp90 protein's pattern of motion paves way for new drug target in cancer therapy

The protein Hsp90 plays a significant role in the survival of cells that are exposed to stress. Researchers at the Technische Universitaet Muenchen (TUM) uncovered this protein's mode of operation some time ago - but now Hsp90 has surprised even the experts with an unexpected pattern of motion. The results are published in the current online issue of the renowned science journal PNAS and may help researchers discover specific cancer medication.

24 Aug 2010

PCF to conduct special Charlie Wilson Concert to support fight against prostate cancer

The Prostate Cancer Foundation (PCF) today announced a special Charlie Wilson Concert for Prostate Cancer. The concert, including performances by Baltimore's famed Soulful Symphony, conducted by Darin Atwater, will take place on Thursday, September 16, 2010 at 8 p.m. at the Warner Theatre in Washington, D.C.

24 Aug 2010

NexMed expands patent protection for Prostaglandin E1 -based products in Israel

NexMed, Inc., backed by a revenue generating CRO business and seeking to leverage its proprietary, multi-route NexACT® drug delivery technology and internal pipeline through out-licensing arrangements and partnerships, today announced that the Israel Patent Office has issued an allowance notice for NexMed's patent application entitled, "Topical Compositions for Prostaglandin E1 Delivery."

24 Aug 2010

Polyphenols affect nutrient absorption: Study

Health benefits from polyphenol antioxidants - substances found in many fruits and vegetables - may come at a cost to some people. Penn State nutritional scientists found that eating certain polyphenols decreased the amount of iron the body absorbs, which can increase the risk of developing an iron deficiency.

24 Aug 2010

Novartis presents 2010 Immunology prizes at 16th International Congress of Immunology in Kobe

The Novartis 2010 Immunology Prizes were presented at the 16th International Congress of Immunology in Kobe, Japan. Since 1992, the Novartis Prizes for Immunology have been awarded every third year for outstanding contributions to basic and clinical immunology. The prizes recognize individual achievement and provide financial support for further research by the recipients. The prizes are a major feature of the triennial International Congress of Immunology.

24 Aug 2010

Cancer News and Research

Latest Cancer News and Research

ACR Image Metrix praises iCAD on FDA clearance of VeraLook Colon CAD software

NICE draft guidance rejects cancer drug bevacizumab

BioScale installs ViBE analytical tool at Massachusetts-based pharmaceutical company

Access Pharmaceuticals to highlight Cobalamin nanotechnology at ACS National Meeting

Fewer young women going for regular pap smears

Scientists discover influence of vitamin D in genes linked with autoimmune diseases

UNT Health Science Center analyzes DNA from unidentified human remains

3SBio and Isotechnika enter strategic agreement for voclosporin in China

First patient treated in Synta Pharmaceuticals' clinical trial of STA-9090

Aileron Therapeutics, Roche partner to develop, commercialise Stapled Peptide Therapeutics

First Edition: August 24, 2010

FRC applauds preliminary injunction to stop taxpayers for embryonic stem cell research

Raptor Pharmaceutical updates on cysteamine bitartrate Phase 3 clinical trial in cystinosis patients

EDAP's gross profit reduces 5.1% in 2010 second quarter

Walter and Eliza Hall Institute researcher receives L'Oreal Fellowship for breast cancer research

Discovery of Hsp90 protein's pattern of motion paves way for new drug target in cancer therapy

PCF to conduct special Charlie Wilson Concert to support fight against prostate cancer

NexMed expands patent protection for Prostaglandin E1 -based products in Israel

Polyphenols affect nutrient absorption: Study

Novartis presents 2010 Immunology prizes at 16th International Congress of Immunology in Kobe

Industry Focus - Oncology (1st Edition) eBook

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Cancer News and Research

Latest Cancer News and Research

Industry Focus - Oncology (1st Edition) eBook

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Newsletters you may be interested in